ONGOING INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Ventyx Biosciences, Inc.'s Directors and Officers for Breach of Fiduciary Duties - VTYX

New York, New York--(Newsfile Corp. - June 14, 2024) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain dir

newsfileJun 14 16:00 ET

H.C. Wainwright Maintains Ventyx Biosciences(VTYX.US) With Hold Rating, Maintains Target Price $6

H.C. Wainwright analyst Emily Bodnar maintains $Ventyx Biosciences(VTYX.US)$ with a hold rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 39.3

moomoo NewsJun 13 15:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Neutral on Ventyx Biosciences, Maintains $6 Price Target

BenzingaJun 13 06:41 ET

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Ventyx Biosciences, Inc.'s Directors and Officers for Breach of Fiduciary Duties - VTYX

New York, New York--(Newsfile Corp. - June 11, 2024) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain dir

newsfileJun 11 08:00 ET

Ventyx Biosciences Insider Sellers Vindicated After 32% Drop

Insiders seem to have made the most of their holdings by selling US$222k worth of Ventyx Biosciences, Inc. (NASDAQ:VTYX) stock at an average sell price of US$2.44 during the past year. The company's

Simply Wall StJun 7 09:05 ET

Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Cuts Target Price to $10

Oppenheimer analyst Jeff Jones maintains $Ventyx Biosciences(VTYX.US)$ with a buy rating, and adjusts the target price from $12 to $10.According to TipRanks data, the analyst has a success rate of 40.

moomoo NewsJun 6 15:31 ET